Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Congenital Athymia Patient Registry of RETHYMIC

NCT05329935 is registered in ClinicalTrials.gov with Sumitomo Pharma Switzerland GmbH as lead sponsor.

NCT NCT05329935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05329935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Congenital Athymia Patient Registry of RETHYMIC
Lead sponsor
Sumitomo Pharma Switzerland GmbH
Phase
Observational
Overall status
Recruiting
Start date
May 25, 2022
Completion date
April 30, 2026
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complete digeorge anomaly, complete digeorge syndrome, congenital athymia